Literature DB >> 3544447

The amino acid factor in stone formers' and normal urines.

R Azoury, N Garti, S Sarig.   

Abstract

The composition of amino-acids in kidney stone matrices and inhibitory materials from normal urines, reported in different independent studies has been reviewed. No obvious difference was found between the composition of amino acids from healthy and pathological sources. Studies carried out in this laboratory showed a specific marked effect of glutamic acid on the crystallization of calcium oxalate while aspartic acid and alanine affected the process very slightly. It is known that aspartic acid and alanine are transformed into glutamic acid by enzyme activity. A short survey performed in this laboratory showed that the relevant enzyme activity was relatively high in healthy urine and low in stone formers' urine. The AA factor (FAA) proposed is FAA = [Glutamic acid]/[( Aspartic acid] + [Alanine]) its value in fractions of non-potent inhibitory material and in kidney stone matrices is below 0.6. In potent portions of the inhibitory material separated from healthy people and young animals urine the value is 0.8 and above.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3544447     DOI: 10.1007/BF00262378

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  17 in total

1.  THE EFFECT OF URINARY AMINO ACIDS UPON THE SOLUBILITY OF CALCIUM OXALATE.

Authors:  J S ELLIOT; E EUSEBIO
Journal:  Invest Urol       Date:  1965-03

2.  The urinary amino acids in relation to calculus disease.

Authors:  M G McGEOWN
Journal:  J Urol       Date:  1957-10       Impact factor: 7.450

3.  Urine polyelectrolytes: binding of phosphate, calcium and magnesium.

Authors:  D W Hamar; F H Chow; R H Udall
Journal:  Biochem Med       Date:  1973-02

4.  Isolation and partial characterization of a low molecular weight trypsin inhibitor from human urine.

Authors:  G Fex; A Grubb; C Loeffler; J Larsson
Journal:  Biochim Biophys Acta       Date:  1981-02-27

5.  A method for discrimination between calcium oxalate kidney stone formers and normals.

Authors:  S Sarig; N Garti; R Azoury; Y Wax; S Perlberg
Journal:  J Urol       Date:  1982-09       Impact factor: 7.450

6.  Isolation and characterization of calcium oxalate crystal growth inhibitors from human urine.

Authors:  Y Nakagawa; E T Kaiser; F L Coe
Journal:  Biochem Biophys Res Commun       Date:  1978-10-30       Impact factor: 3.575

7.  May enzyme activity in urine play a role in kidney stone formation?

Authors:  R Azoury; N Garti; S Perlberg; S Sarig
Journal:  Urol Res       Date:  1982

8.  Retardation of calcium oxalate precipitation by glutamic-oxalacetic-transaminase activity.

Authors:  R Azoury; S Sarig; N Garti; S Perlberg
Journal:  Urol Res       Date:  1982

9.  The paradox of inhibition and enhancement of the formation of urinary stones.

Authors:  G W Drach; S Sarig; A D Randolph; S Thorson
Journal:  Urol Res       Date:  1982

10.  Control of oxalate urolithiasis by DL-alanine.

Authors:  F C Chow; M I Dysart; D W Hamar; R H Udall
Journal:  Invest Urol       Date:  1975-09
View more
  3 in total

1.  Influence of the lysine on the calcium oxalate renal calculi.

Authors:  Stoyanka S Atanassova
Journal:  Int Urol Nephrol       Date:  2013-09-21       Impact factor: 2.370

Review 2.  The Molecular Aspect of Nephrolithiasis Development.

Authors:  Paulina Wigner; Radosław Grębowski; Michal Bijak; Janusz Szemraj; Joanna Saluk-Bijak
Journal:  Cells       Date:  2021-07-29       Impact factor: 6.600

3.  Lack of evidence for the association of ornithine decarboxylase (+316 G>A), spermidine/spermine acetyl transferase (-1415 T>C) gene polymorphisms with calcium oxalate stone disease.

Authors:  Ajda Coker-Gürkan; Serdar Arisan; Elif Damla Arisan; Narçin Palavan Unsal
Journal:  Biomed Rep       Date:  2013-10-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.